These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 9051240

  • 21. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
    Greenberg P, Advani R, Keating A, Gulati SC, Nimer S, Champlin R, Karanes C, Gorin NC, Powles RL, Smith A, Lamborn K, Cuffie C.
    Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
    [Abstract] [Full Text] [Related]

  • 22. Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitro.
    Millar BC, Bell JB, Millar JL, Treleaven J, Montes A, Joffe JK, Powles RL, McElwain TJ.
    Exp Hematol; 1992 Feb; 20(2):209-15. PubMed ID: 1371966
    [Abstract] [Full Text] [Related]

  • 23. Enrichment of peripheral blood stem cells in a primate model following administration of a single dose of rh-IL-1 beta.
    Gasparetto C, Smith C, Gillio A, Stoppa AM, Moore MA, O'Reilly RJ.
    Bone Marrow Transplant; 1994 Nov; 14(5):717-23. PubMed ID: 7534159
    [Abstract] [Full Text] [Related]

  • 24. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Nov; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 25. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F.
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [Abstract] [Full Text] [Related]

  • 26. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
    Baiocchi G, Scambia G, Benedetti P, Menichella G, Testa U, Pierelli L, Martucci R, Foddai ML, Bizzi B, Mancuso S.
    Cancer Res; 1993 Mar 15; 53(6):1297-303. PubMed ID: 7680283
    [Abstract] [Full Text] [Related]

  • 27. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH, Schulman KA, Buckner CD.
    Bone Marrow Transplant; 2001 May 15; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [Abstract] [Full Text] [Related]

  • 28. Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantation.
    Stoppa AM, Blaise D, Viens P, Baume D, Mannoni P, Novakovitch G, David FA, Yver A, Maraninchi D.
    Bone Marrow Transplant; 1994 May 15; 13(5):541-7. PubMed ID: 7519936
    [Abstract] [Full Text] [Related]

  • 29. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L, Gorin NC, Mary JY, Lemarie E, Lopez M, Najman A, Stachowiak J, Giarratana MC, Baillou C, Salmon C.
    Exp Hematol; 1986 Jun 15; 14(5):358-65. PubMed ID: 3519263
    [Abstract] [Full Text] [Related]

  • 30. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis.
    Peters BG, Adkins DR, Harrison BR, Velasquez WS, Dunphy FR, Petruska PJ, Bowers CE, Niemeyer R, McIntyre W, Vrahnos D, Auberry SE, Spitzer G.
    Bone Marrow Transplant; 1996 Jul 15; 18(1):93-102. PubMed ID: 8832001
    [Abstract] [Full Text] [Related]

  • 31. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S.
    Cytokines Mol Ther; 1995 Mar 15; 1(1):47-55. PubMed ID: 9384663
    [Abstract] [Full Text] [Related]

  • 32. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.
    Grigg A, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM, Sheridan WP.
    Bone Marrow Transplant; 1993 Mar 15; 11 Suppl 2():23-9. PubMed ID: 8334435
    [Abstract] [Full Text] [Related]

  • 33. GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation.
    Zumberg MS, Leather HL, Nejame C, Meyer C, Wingard JR.
    Cytotherapy; 2002 Mar 15; 4(6):531-8. PubMed ID: 12568989
    [Abstract] [Full Text] [Related]

  • 34. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
    Bernstein SH, Fay JP, Christiansen NP, Pinero L, Shah D, Stephan M, Herzig GP.
    Clin Cancer Res; 1997 Sep 15; 3(9):1519-26. PubMed ID: 9815838
    [Abstract] [Full Text] [Related]

  • 35. Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease.
    Klingemann HG, Wilkie-Boyd K, Rubin A, Onetto N, Nantel SH, Barnett MJ, Reece DE, Shepherd JD, Phillips GL.
    Biotechnol Ther; 1994 Sep 15; 5(1-2):1-13. PubMed ID: 7703829
    [Abstract] [Full Text] [Related]

  • 36. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma.
    Fay JW, Bernstein SH.
    Semin Oncol; 1996 Apr 15; 23(2 Suppl 4):22-7. PubMed ID: 8600545
    [Abstract] [Full Text] [Related]

  • 37. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
    Vanásek J, Filip S, Medková V, Bláha M, Mericka P, Volenec K.
    Bone Marrow Transplant; 1998 Jan 15; 21(2):123-6. PubMed ID: 9489627
    [Abstract] [Full Text] [Related]

  • 38. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation.
    Haas R, Gericke G, Witt B, Cayeux S, Hunstein W.
    Exp Hematol; 1993 Jan 15; 21(1):109-13. PubMed ID: 7678083
    [Abstract] [Full Text] [Related]

  • 39. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K, Margolin K, Champlin R, Forman S.
    Cancer J Sci Am; 1997 Dec 15; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [Abstract] [Full Text] [Related]

  • 40. Granulocyte-macrophage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma.
    Colombat P, Delain M, Desbois I, Domenech J, Binet C, Tabah I, Lamagnere JP, Linassier C.
    Bone Marrow Transplant; 1996 Aug 15; 18(2):293-9. PubMed ID: 8864437
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.